The versatility of a glycerol-preserved skin allograft as an adjunctive treatment to free flap reconstruction

ABSTRACT

Skin allografts have been used in medical practice for over a century owing to their unique composition as a biological dressing. Skin allografts can be obtained in several preparations such as cryopreserved, glycerol-preserved, and fresh allograft. A glycerol-preserved allograft (GPA) was introduced in the early 1980s. It has several advantages compared with other dressings such as ease of processing, storage and transport, lower cost, less antigenicity, antimicrobial properties, and neo-vascularisation promoting properties. Skin allografts are mainly used in the management of severe burn injuries, chronic ulcers, and complex, traumatic wounds. Published reports of the use of skin allografts in association with free flap surgery are few or non existent. We would like to share our experience of several cases of free tissue transfer that utilised GPA as a temporary wound dressing in multiple scenarios. On the basis of this case series, we would like to recommend that a GPA be used as a temporary dressing in conjunction with free flap surgery when required to protect the flap pedicle, allowing time for the edema to subside and the wound can then be closed for a better aesthetic outcome.

KEY WORDS

Free flap - Free tissue transfer - Skin allograft

• REFERENCES

• 1 Ben-Bassat H. Performance and safety of skin allografts. Clin Dermatol 2005;23:365-75.
• 2 Moerman E, Middlekoop E, Mackie D, Groenevelt F. The temporary use of allograft for complicate wounds in plastic surgery. Burns 2002;28:S13-15.
• 3 Vleomans AF, Middlekoop E, Kreis RW. A historical appraisal of the use of cryopreserved and glycerol-preserved allograft skin in the treatment of partial thickness burns. Burns 2002;28:S16-20.
• 4 Druecke D, Steinstraesser L, Homann HH, Steinau HU, Vogt PM. Current indications for glycerol-preserved allograft in the treatment of burns injuries. Burns 2002;28:S26-30.
• 5 Das De S, Tai LS, Pho RW. Emergency repair and reconstruction in the severely crushed hand. World J Surg 1991;15:470-6.
• 6 Groenevelt F, van Trier AJ, Khouw YL. The use of allografts in the management of exposed calvarial electrical burn wounds of the skull. Ann N Y Acad Sci 1999;888:109-12.
• 7 Snyder RJ. Treatment of nonhealing ulcers with allografts. Clin Dermatol 2005;23:388-95.
• 8 Blome-Eberwein S, Jester A, Kuentscher M, Raff T, Germann G, Pelzer M. Clinical practice of glycerol preserved allograft skin coverage. Burn 2002;28:S10-2.
• 9 Ricthers CD, Hoekstra M, Van Baare J, Du pont JS, Keamperdijk EW. Immunogenicity of Glycerol-preserved human Cadaver skin in vitro. J Burn Care Rehab 1997;18:1173-6.
• 10 Cameron PU, Pagnon JC, Van Baare J. Efficacy and kinetics of glycerol inactivation of HIV-1 in split skin graft. J Med Virol 2000;60:1182-8.
• 11 Marshall L, Gosh MM, Boyce SG. Effect of glycerol on intracellular viral survival; Implications for the clinical use of glycerol preserved cadaver skin. Burns 1995;21:356-61.
• 12 Mackie DP. The Euro Skin Bank: Development and Application of Glycerol-Preserved Allograft. J Burn Care Rehab 1997;18:7-9.
• 13 Vloemans AF, Schreinemachers MC, Middelkoop E, Kreis RW. The use of glycerol-preserved allografts in the Beverwijk Burn Centre: A retrospective study. Burns 2002;28:S2-9.
• 14 Khoo TL, Mat Saad AZ, Dorai AA, Halim AS. The application of glycerol-preserved skin allograft in the treatment of burn injuries: An analysis by indications. [In press].